Estados Unidos · Bolsa y Finanzas · TheStreet

AARP exposes how drugmakers delay cheaper generics

Publicado por TheStreet · Estados Unidos hace 11 h

A new AARP report shows how patent thickets, tweaked products and price hikes slow generic competition, and what you can do during open enrollment.

Leer el artículo completo en TheStreet Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.thestreet.com)

También te puede interesar

Boomers are buying into the promise of monthly income from options ETFs, but there's a tax catch

Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review

Total Energy plans share buyback

Accenture is looking to sell Greater China business for up to $1.5 billion, FT report says

Business Insider

Barbara Palvin says she doesn't want praise for walking the Victoria's Secret fashion show 6 weeks postpartum

Elon Musk Says He Will Give a SpaceX Share to ‘Every Kid in America’